東華大學圖書館 |

Recent advances in human fungal diseases = progress and prospects /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Recent advances in human fungal diseases/ edited by Saif Hameed, Pooja Vijayaraghavan.
其他題名:	progress and prospects /
其他作者:	Hameed, Saif.
出版者:	Singapore :Springer Nature Singapore : : 2024.,
面頁冊數:	xvi, 475 p. :ill., digital ;24 cm.
內容註:	Part I. Candida and candidiasis -- Chapter 1. Diagnosis of candida and candidiasis: current methods and future challenges -- Chapter 2. Fungal fighters: a comprehensive guide to antifungal therapies of the past, present and future -- Chapter 3. Candidiasis treatment: an evolutionary journey from past to present and a glimse into the future -- Chapter 4. MDR in candida: the real storm -- Chapter 5. Surviving the storm: how candida species master adaptation for pathogenesis -- Chapter 6. Molecular cues and mechanisms of pathogenesis in candida -- Chapter 7. Factors affecting drug resistance and virulence in fungal pathogen -- Chapter 8. Unravelling drug resistance in candida species: genetic, biofilm, transcriptional and epigenetic perspectives -- Chapter 9. Biofilm formation in candida species -- Chapter 10. Candida auris biofilm: a medical ambrosia -- Chapter 11. Candida albicans mixed species biofilms and associated antimicrobial resistance -- Chapter 12. Decoding the complex terrain of candida tropicalis induced candidiasis: insights into epidemology, infection mechanisms, theraputics and drug resistance -- Chapter 13. Candiasis drug resistance and translational research -- Part II. Aspergillus and aspergillosis -- Chapter 14. Therapeutic strategies and challenges in the management of aspergillus infections -- Chapter 15. Aspergillus therapeutics: future agents -- Chapter 16. Recent advances in the management of aspergillosis -- Chapter 17. Drug resistance patterns in opportunistic aspergilli: a molecular perspective -- Chapter 18. A comprehensive and intricate dynamics of aspergillus: implications, therapeutic challenges, and drug resistance -- Chapter 19. Understanding molecular pathogenesis of aspergillus fumigatus.
Contained By:	Springer Nature eBook
標題:	Mycoses. -
電子資源:	https://doi.org/10.1007/978-981-97-4909-6
ISBN:	9789819749096

Recent advances in human fungal diseases = progress and prospects /
Recent advances in human fungal diseasesprogress and prospects /[electronic resource] :edited by Saif Hameed, Pooja Vijayaraghavan. - Singapore :Springer Nature Singapore :2024. - xvi, 475 p. :ill., digital ;24 cm.

Part I. Candida and candidiasis -- Chapter 1. Diagnosis of candida and candidiasis: current methods and future challenges -- Chapter 2. Fungal fighters: a comprehensive guide to antifungal therapies of the past, present and future -- Chapter 3. Candidiasis treatment: an evolutionary journey from past to present and a glimse into the future -- Chapter 4. MDR in candida: the real storm -- Chapter 5. Surviving the storm: how candida species master adaptation for pathogenesis -- Chapter 6. Molecular cues and mechanisms of pathogenesis in candida -- Chapter 7. Factors affecting drug resistance and virulence in fungal pathogen -- Chapter 8. Unravelling drug resistance in candida species: genetic, biofilm, transcriptional and epigenetic perspectives -- Chapter 9. Biofilm formation in candida species -- Chapter 10. Candida auris biofilm: a medical ambrosia -- Chapter 11. Candida albicans mixed species biofilms and associated antimicrobial resistance -- Chapter 12. Decoding the complex terrain of candida tropicalis induced candidiasis: insights into epidemology, infection mechanisms, theraputics and drug resistance -- Chapter 13. Candiasis drug resistance and translational research -- Part II. Aspergillus and aspergillosis -- Chapter 14. Therapeutic strategies and challenges in the management of aspergillus infections -- Chapter 15. Aspergillus therapeutics: future agents -- Chapter 16. Recent advances in the management of aspergillosis -- Chapter 17. Drug resistance patterns in opportunistic aspergilli: a molecular perspective -- Chapter 18. A comprehensive and intricate dynamics of aspergillus: implications, therapeutic challenges, and drug resistance -- Chapter 19. Understanding molecular pathogenesis of aspergillus fumigatus.

The book explores Candida and candidiasis, and Aspergillus and aspergillosis, two significant fungal infectious diseases. In the first section, various aspects of Candida infection are covered. The book delves into the epidemiology of Candida infections, highlighting their prevalence and distribution. It thoroughly discusses diagnostics and pathogenesis of candidiasis, providing valuable insights into the identification, and understanding of the disease. Additionally, the book addresses the growing concern of drug resistance and provides an overview of current therapeutics for candidiasis. Chapters in the second section examine the epidemiology of Aspergillus infections, providing a comprehensive understanding of their occurrence and impact. It discusses the diagnostics and pathogenesis of aspergillosis, shedding light on the methods for accurate diagnosis and the mechanisms by which the infection develops. It explores the host-pathogen interaction and the role of biofilms in these infections. Furthermore, the book addresses the pressing issue of drug resistance in aspergillosis and presents an overview of therapeutic approaches available for managing the disease. This book serves as a valuable resource for researchers, clinicians, and healthcare professionals seeking in-depth knowledge of these fungal infectious diseases.

ISBN: 9789819749096

Standard No.: 10.1007/978-981-97-4909-6doiSubjects--Topical Terms:

828254
Mycoses.

LC Class. No.: RC117 / .R43 2024

Dewey Class. No.: 616.969

Recent advances in human fungal diseases = progress and prospects /
LDR:04119nmm a2200325 a 4500 001 2380709
003 DE-He213
005 20241122115223.0
006 m d
007 cr nn 008maaau
008 250418s2024 si s 0 eng d
020 $a 9789819749096 $q (electronic bk.)
020 $a 9789819749089 $q (paper)
024 7 $a 10.1007/978-981-97-4909-6 $2 doi
035 $a 978-981-97-4909-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC117 $b .R43 2024
072 7 $a PSG $2 bicssc
072 7 $a SCI045000 $2 bisacsh
072 7 $a PSG $2 thema
082 0 4 $a 616.969 $2 23
090 $a RC117 $b .R295 2024
245 0 0 $a Recent advances in human fungal diseases $h [electronic resource] : $b progress and prospects / $c edited by Saif Hameed, Pooja Vijayaraghavan.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a xvi, 475 p. : $b ill., digital ; $c 24 cm.
505 0 $a Part I. Candida and candidiasis -- Chapter 1. Diagnosis of candida and candidiasis: current methods and future challenges -- Chapter 2. Fungal fighters: a comprehensive guide to antifungal therapies of the past, present and future -- Chapter 3. Candidiasis treatment: an evolutionary journey from past to present and a glimse into the future -- Chapter 4. MDR in candida: the real storm -- Chapter 5. Surviving the storm: how candida species master adaptation for pathogenesis -- Chapter 6. Molecular cues and mechanisms of pathogenesis in candida -- Chapter 7. Factors affecting drug resistance and virulence in fungal pathogen -- Chapter 8. Unravelling drug resistance in candida species: genetic, biofilm, transcriptional and epigenetic perspectives -- Chapter 9. Biofilm formation in candida species -- Chapter 10. Candida auris biofilm: a medical ambrosia -- Chapter 11. Candida albicans mixed species biofilms and associated antimicrobial resistance -- Chapter 12. Decoding the complex terrain of candida tropicalis induced candidiasis: insights into epidemology, infection mechanisms, theraputics and drug resistance -- Chapter 13. Candiasis drug resistance and translational research -- Part II. Aspergillus and aspergillosis -- Chapter 14. Therapeutic strategies and challenges in the management of aspergillus infections -- Chapter 15. Aspergillus therapeutics: future agents -- Chapter 16. Recent advances in the management of aspergillosis -- Chapter 17. Drug resistance patterns in opportunistic aspergilli: a molecular perspective -- Chapter 18. A comprehensive and intricate dynamics of aspergillus: implications, therapeutic challenges, and drug resistance -- Chapter 19. Understanding molecular pathogenesis of aspergillus fumigatus.
520 $a The book explores Candida and candidiasis, and Aspergillus and aspergillosis, two significant fungal infectious diseases. In the first section, various aspects of Candida infection are covered. The book delves into the epidemiology of Candida infections, highlighting their prevalence and distribution. It thoroughly discusses diagnostics and pathogenesis of candidiasis, providing valuable insights into the identification, and understanding of the disease. Additionally, the book addresses the growing concern of drug resistance and provides an overview of current therapeutics for candidiasis. Chapters in the second section examine the epidemiology of Aspergillus infections, providing a comprehensive understanding of their occurrence and impact. It discusses the diagnostics and pathogenesis of aspergillosis, shedding light on the methods for accurate diagnosis and the mechanisms by which the infection develops. It explores the host-pathogen interaction and the role of biofilms in these infections. Furthermore, the book addresses the pressing issue of drug resistance in aspergillosis and presents an overview of therapeutic approaches available for managing the disease. This book serves as a valuable resource for researchers, clinicians, and healthcare professionals seeking in-depth knowledge of these fungal infectious diseases.
650 0 $a Mycoses. $3 828254
650 0 $a Medical mycology. $3 899351
650 1 4 $a Microbiology. $3 536250
650 2 4 $a Fungi. $3 571472
650 2 4 $a Biological Sciences. $3 1363809
650 2 4 $a Tumour Virus Infections. $3 3626016
650 2 4 $a Drug Delivery. $3 3531319
650 2 4 $a Drug Safety and Pharmacovigilance. $3 2108855
700 1 $a Hameed, Saif. $3 3500650
700 1 $a Vijayaraghavan, Pooja. $3 3734334
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-97-4909-6
950 $a Biomedical and Life Sciences (SpringerNature-11642)